VRNOD (Verano Holdings) Beneish M-Score: -2.88 (As of Jun. 24, 2026)


VRNOD Verano Holdings Corp VRNOD
65 GF Score
Price $5.31
GF Value $7.76
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Verano Holdings Beneish M-Score?

Verano Holdings VRNOD +0.19% 65 Beneish M-Score is -2.88 as of Jun. 24, 2026. GuruFocus rates VRNOD with a GF Score™ of 65/100 and a GF Value™ of $7.76 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 911 Drug Manufacturers companies, Verano Holdings ranks better than 79.25% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.88 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Verano Holdings's Beneish M-Score or its related term are showing as below:

VRNOD' s Beneish M-Score Range Over the Past 10 Years
Min: -3.41   Med: -2.73   Max: -1.75
Current: -2.88

During the past 7 years, the highest Beneish M-Score of Verano Holdings was -1.75. The lowest was -3.41. And the median was -2.73.


Verano Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Verano Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verano Holdings Beneish M-Score Chart

Verano Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 -2.99 -1.78 -2.55 -2.95

Verano Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 -3.03 -2.98 -2.95 -2.88

VRNOD vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Verano Holdings Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Verano Holdings's Beneish M-Score falls into.


VRNOD
65GF Score
Verano Holdings Corp VRNOD
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Verano Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Verano Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1479+0.528 * 0.986+0.404 * 0.8668+0.892 * 0.9455+0.115 * 1.0092
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0368+4.679 * -0.078248-0.327 * 1.0217
=-2.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $43.4 Mil.
Revenue was 208.178 + 206.613 + 202.81 + 202.272 = $819.9 Mil.
Gross Profit was 98.976 + 105.695 + 95.237 + 112.984 = $412.9 Mil.
Total Current Assets was $394.5 Mil.
Total Assets was $1,708.3 Mil.
Property, Plant and Equipment(Net PPE) was $578.2 Mil.
Depreciation, Depletion and Amortization(DDA) was $133.6 Mil.
Selling, General, & Admin. Expense(SGA) was $343.8 Mil.
Total Current Liabilities was $118.9 Mil.
Long-Term Debt & Capital Lease Obligation was $473.4 Mil.
Net Income was -17.823 + -183.411 + -43.832 + -19.15 = $-264.2 Mil.
Non Operating Income was -6.987 + -179.924 + -16.856 + 3.57 = $-200.2 Mil.
Cash Flow from Operations was 18.587 + 13.815 + 26.354 + 10.9 = $69.7 Mil.
Total Receivables was $40.0 Mil.
Revenue was 209.809 + 218.206 + 216.683 + 222.39 = $867.1 Mil.
Gross Profit was 99.581 + 107.534 + 109.097 + 114.34 = $430.6 Mil.
Total Current Assets was $361.1 Mil.
Total Assets was $1,969.0 Mil.
Property, Plant and Equipment(Net PPE) was $629.7 Mil.
Depreciation, Depletion and Amortization(DDA) was $147.1 Mil.
Selling, General, & Admin. Expense(SGA) was $350.7 Mil.
Total Current Liabilities was $167.6 Mil.
Long-Term Debt & Capital Lease Obligation was $500.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(43.436 / 819.873) / (40.017 / 867.088)
=0.052979 / 0.046151
=1.1479

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(430.552 / 867.088) / (412.892 / 819.873)
=0.496549 / 0.503605
=0.986

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (394.521 + 578.228) / 1708.348) / (1 - (361.141 + 629.682) / 1968.982)
=0.430591 / 0.496784
=0.8668

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=819.873 / 867.088
=0.9455

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(147.133 / (147.133 + 629.682)) / (133.591 / (133.591 + 578.228))
=0.189405 / 0.187676
=1.0092

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(343.828 / 819.873) / (350.734 / 867.088)
=0.419367 / 0.404496
=1.0368

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((473.357 + 118.911) / 1708.348) / ((500.504 + 167.644) / 1968.982)
=0.34669 / 0.339337
=1.0217

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-264.216 - -200.197 - 69.656) / 1708.348
=-0.078248

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Verano Holdings has a M-score of -2.83 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.88 mean?
Verano Holdings (VRNOD) has a Beneish M-Score of -2.88 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Verano Holdings and its competitors. According to the industry distribution chart, Verano Holdings ranks #189 out of 911 companies in the Drug Manufacturers industry, placing it in the top 20.7%.
Is Verano Holdings' Beneish M-Score too high?
Verano Holdings' current Beneish M-Score is -2.88. Based on the distribution chart, Verano Holdings ranks #189 out of 911 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Verano Holdings has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #189 out of 911 companies for Beneish M-Score. This places Verano Holdings in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Verano Holdings and its competitors. Verano Holdings's current Beneish M-Score is -2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (VRNOD) is currently considered Possible Value Trap. The stock's GF Value™ is $7.76, compared to a current price of $5.31 — trading 31.6% below its estimated fair value. The current Beneish M-Score is -2.88. Verano Holdings' overall GF Score™ is 65/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Verano Holdings (VRNOD), the current Beneish M-Score is -2.88 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Verano Holdings (VRNOD) Overvalued in 2026?

Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued. The current stock price of $5.31 is trading 31.6% below its estimated GF Value™ of $7.76. GuruFocus considers Verano Holdings to be Possible Value Trap.

Key valuation signals for VRNOD:

  • Beneish M-Score: -2.88
  • GF Value™: $7.76 vs. price of $5.31 (31.6% below fair value)
  • GF Score™: 65/100 with 7 warning signs

No single metric tells the full story. See the VRNOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Verano Holdings Business Description

Other Exchanges H7P0:GermanyVRNO:Canada
Address 224 West Hill Street, Suite 400, Chicago, IL, USA, 60610
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
65GF Score

Get the complete analysis for VRNOD

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.31
Price
$7.76
GF Value